2024 Topps #277 Jordan Westburg
Jordan Westburg · Baltimore Orioles · High confidence
Player Stats
Grade Price Ladder
VerifiedMarket Snapshot
Analysis
This is a 2024 Topps base flagship card — unnumbered, with a massive print run and a raw value of just $1.36, meaning the PSA 10 premium is almost entirely a grading arbitrage story, not a scarcity story. The core thesis for holding Westburg's card just collapsed: he underwent Tommy John surgery in May 2026 and will miss the entire season, with a best-case return in early 2027. His injury history is alarming — he has never played more than 107 games in a season, suffering a hand fracture in 2024, hamstring and ankle issues in 2025, and now UCL surgery in 2026. At $25 for a PSA 10 of a base Topps card, the risk/reward is poor: there is no near-term on-field catalyst, the 2026 Bowman Mega Box releases May 28 adding supply pressure, and recovery from TJ surgery typically takes 12–18 months for position players. Sell now and re-enter when he returns healthy in 2027.
Long-Term Outlook
Westburg has legitimate All-Star upside — his 2024 campaign (.264/.312/.792, 18 HR, 63 RBI) was legitimately elite, and his Statcast profile (90.2 mph avg exit velo, 11.2 barrel%, 43.4 hard hit%) reflects a real plus-power bat. He remains under team control through 2029, giving him runway to rebuild value. However, this is a base Topps flagship card with no numbered print run, and modern unnumbered base cards face perpetual junk-wax-era supply risk. Long-term card upside is capped without a numbered parallel, an auto, or a sustained MVP-caliber performance run. A clean return in 2027 could push this to $35–$45 on hype, but the ceiling is low for this specific card.
The case for
Westburg's 2024 All-Star season and strong Statcast metrics (11.2% barrel rate, 90.2 mph exit velo) confirm he is a legitimate impact bat when healthy.
At $25, some TJ surgery discount may already be partially priced in; position players often return faster than the 12-18 month pitcher timeline.
Team control through 2029 gives Westburg time to build a long career arc that supports card value sustainment.
BGS 10 is at $33, suggesting crossover grade demand exists and some collectors will pay up for gem copies.
The case against
Tommy John surgery confirmed May 2026 — zero games played this season and no return until at minimum early 2027, eliminating all near-term on-field catalysts.
This is an unnumbered 2024 Topps base card with a raw value of $1.36 — massive print run, no scarcity, and junk-wax-era supply risk.
Westburg has never played more than 107 games in a season; chronic injury history (hand, hamstring, ankle, now UCL) is a real pattern, not bad luck.
44 annual sales volume is thin; if a few sellers panic-list post-surgery news, the $25 price can gap down quickly with limited buyer depth.
2026 Bowman Baseball Mega Box releases May 28 — new supply event will suppress Orioles card demand short-term.
PSA 9 trades at only $8 — the 3.1x PSA 10 premium is entirely dependent on gem-rate demand, which evaporates when the player is off the field.
Key Dates Ahead
Spring Training 2027 — earliest realistic return from Tommy John surgery; healthy appearance would be the primary re-entry catalyst.HIGH
2026 Bowman Chrome expected release window — annual prospect product floods market and competes for collector dollars.MEDIUM
Recent Updates
Westburg underwent Tommy John surgery and will miss the entire 2026 season; GM Mike Elias confirmed the procedure with a possible return to the field by early 2027.
NEGATIVE· May 15, 2026
Westburg was shut down from his throwing program after feeling renewed discomfort in his right elbow, prompting the surgical decision.
NEGATIVE· May 7, 2026
Westburg placed on the 60-day IL with a partial UCL tear in his right elbow; has not appeared in a single game in 2026.
NEGATIVE· Apr 2, 2026
2026 Bowman Baseball Mega Box releasing May 28, 2026 — fresh supply event flooding the market with new Orioles cards.
NEGATIVE· May 28, 2026
2025 season limited to 85 games due to left hamstring strain and right ankle sprain, continuing a chronic injury pattern.
NEGATIVE· Oct 1, 2025
Ownership Analysis
PSA 10 population continues to grow as collectors submit modern base Topps cards, steadily eroding scarcity and suppressing long-term price ceilings.
Sell triggers
Sell immediately if Westburg's recovery timeline extends beyond early 2027 or any setback is reported.
Sell before the 2026 Bowman Chrome release window (est. September 2026), which will pull speculative dollars toward new prospect cards.
Sell if price drops below $20 — thin volume means limited support floor on a base card with no print run scarcity.
Sell if another Orioles player (Gunnar Henderson, Jackson Holliday) has a breakout moment that diverts collector attention within the franchise.
Hold reasons
Hold if you believe Westburg returns healthy for a full 2027 season and recaptures All-Star-level production, which could push PSA 10 back to $35–$45.
Hold if you have a low cost basis below $15 — the risk/reward of waiting for a 2027 return is more tolerable at that entry.
Hold if Orioles make a postseason run in 2026 that reignites broad franchise demand even without Westburg.
Hold if you want exposure to a young, team-controlled Orioles core player at a low absolute dollar amount ($25).
base Topps supply overhang prevents anything higher.
CardSignal provides data and analysis for informational purposes only. This is not financial or investment advice. All buying, selling, and trading decisions are made at your own risk. Past performance does not guarantee future results.